Ahmed Elkamhawy

25PUBLICATIONS
28CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesCheminformatics and quantitative structure-activity relationshipsAutonomic nervous systemBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jan 20, 2025
Pyrimidine scaffold dual-target kinase inhibitors for cancer diseases: A review on design strategies, synthetic approaches, and structure-activity relationship (2018‒2023).

Moeun Song, Ahmed Elkamhawy, Woojeong Noh

|Jan 08, 2025
Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging Targets.

Hwayoung Lee, Ahmed Elkamhawy, Polina Rakhalskaya

|Sep 06, 2024
Chalcone-based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies.

Hwa Young Lee, Ahmed Elkamhawy, Ahmed A Al-Karmalawy

|Apr 27, 2024
Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 876.

Mohamed H Elsherbeny, Usama M Ammar, Magda H Abdellattif

|Nov 11, 2023
Therapeutic potential of natural products in inflammation: underlying molecular mechanisms, clinical outcomes, technological advances, and future perspectives.

Noha A Gouda, Saud O Alshammari, Mohammed A S Abourehab

|Jun 10, 2023
Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure-Activity Relationship (SAR).

Sreenivasulu Godesi, Joohan Lee, Hossam Nada

Pageof 5

Frequent Collaborators

9 joint publications

Hossam Nada

5 joint publications

Magda H Abdellattif

4 joint publications

Mohamed H Elsherbeny

4 joint publications

Mohammed A S Abourehab